Abstract
Aminoglycosides are one of the common classes of antibiotics that have been widely used for treating infections caused by pathogenic bacteria. The mechanism of bactericidal action by aminoglycosides is well-known, by which it terminates the cytoplasmic protein synthesis. However, the potentials of aminoglycosides become hindered when facing the evolution of bacterial resistance mechanisms. Among multiple resistance mechanisms displayed by bacteria against antibiotics, the formation of biofilm is the mechanism that provides a barrier for antibiotics to reach the cellular level. Bacteria present in the biofilm also get protection against the impact of host immune responses, harsh environmental conditions, and other antimicrobial treatments. Hence, with the multifaceted resistance developed by biofilm-forming pathogenic bacteria, antibiotics are therefore discontinued for further applications. However, the recent research developed several alternative strategies such as optimization of the active concentration, modification of the environmental conditions, modification of the chemical structure, combinatorial application with other active agents, and formulation with biocompatible carrier materials to revitalize and exploit the new potential of aminoglycosides. The present review article describes the above mentioned multiple approaches and possible mechanisms for the application of aminoglycosides to treat biofilm-associated infections.
Similar content being viewed by others
References
Abed N, Couvreur P (2014) Nanocarriers for antibiotics: a promising solution to treat intracellular bacterial infections. Int J Antimicrob Agents 43(6):485–496. https://doi.org/10.1016/j.ijantimicag.2014.02.009
Aderibigbe BA (2017) Metal-based nanoparticles for the treatment of infectious diseases. Molecules 22(8). https://doi.org/10.3390/molecules22081370
Agnihotri S, Pathak R, Jha D, Roy I, Gautam HK, Sharma AK, Kumar P (2015) Synthesis and antimicrobial activity of aminoglycoside-conjugated silica nanoparticles against clinical and resistant bacteria. New J Chem 39(9):6746–6755. https://doi.org/10.1039/C5NJ00007F
Aka ST, Haji SH (2015) Sub-MIC of antibiotics induced biofilm formation of Pseudomonas aeruginosa in the presence of chlorhexidine. Braz J Microbiol 46(1):149–154. https://doi.org/10.1590/S1517-838246120140218
Alhariri M, Majrashi MA, Bahkali AH, Almajed FS, Azghani AO, Khiyami MA, Alyamani EJ, Aljohani SM, Halwani MA (2017) Efficacy of neutral and negatively charged liposome-loaded gentamicin on planktonic bacteria and biofilm communities. Int J Nanomedicine 12:6949–6961. https://doi.org/10.2147/IJN.S141709
Alipour M, Suntres ZE (2014) Liposomal antibiotic formulations for targeting the lungs in the treatment of Pseudomonas aeruginosa. Ther Deliv 5(4):409–427. https://doi.org/10.4155/tde.14.13
Allahverdiyev AM, Kon KV, Abamor ES, Bagirova M, Rafailovich M (2011) Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents. Expert Rev Anti-Infect Ther 9(11):1035–1052. https://doi.org/10.1586/eri.11.121
Anderson GG, Kenney TF, Macleod DL, Henig NR, O’Toole GA (2013) Eradication of Pseudomonas aeruginosa biofilms on cultured airway cells by a fosfomycin/tobramycin antibiotic combination. Pathog Dis 67(1):39–45. https://doi.org/10.1111/2049-632X.12015
Andonova V (2017) Synthetic polymer-based nanoparticles: intelligent drug delivery systems. In: Boreddy S.R. Reddy (ed) Acrylic polymers in healthcare, IntechOpen. https://doi.org/10.5772/intechopen.69056
Ashrafudoulla M, Mizan MFR, Park H, Byun KH, Lee N, Park SH, Ha SD (2019) Genetic relationship, virulence factors, drug resistance profile and biofilm formation ability of Vibrio parahaemolyticus isolated from mussel. Front Microbiol 10:513. https://doi.org/10.3389/fmicb.2019.00513
Bahamondez-Canas TF, Zhang H, Tewes F, Leal J, Smyth HDC (2018) PEGylation of tobramycin improves mucus penetration and antimicrobial activity against Pseudomonas aeruginosa biofilms in vitro. Mol Pharm 15(4):1643–1652. https://doi.org/10.1021/acs.molpharmaceut.8b00011
Bahari S, Zeighami H, Mirshahabi H, Roudashti S, Haghi F (2017) Inhibition of Pseudomonas aeruginosa quorum sensing by subinhibitory concentrations of curcumin with gentamicin and azithromycin. J Glob Antimicrob Resist 10:21–28. https://doi.org/10.1016/j.jgar.2017.03.006
Bai AJ, Rai VR (2011) Bacterial quorum sensing and food industry. Compr Rev Food Sci Food Saf 10(3):183–193. https://doi.org/10.1111/j.1541-4337.2011.00150.x
Bandara HM, Harb A, Kolacny D Jr, Martins P, Smyth HD (2014) Sound waves effectively assist tobramycin in elimination of Pseudomonas aeruginosa biofilms in vitro. AAPS PharmSciTech 15(6):1644–1654. https://doi.org/10.1208/s12249-014-0200-1
Baptista PV, McCusker MP, Carvalho A, Ferreira DA, Mohan NM, Martins M, Fernandes AR (2018) Nano-strategies to fight multidrug resistant bacteria—“a battle of the titans”. Front Microbiol 9:1441. https://doi.org/10.3389/fmicb.2018.01441
Barraud N, Hassett DJ, Hwang SH, Rice SA, Kjelleberg S, Webb JS (2006) Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa. J Bacteriol 188(21):7344–7353. https://doi.org/10.1128/JB.00779-06
Benhamou RI, Shaul P, Herzog IM, Fridman M (2015) Di-N-methylation of anti-gram-positive aminoglycoside-derived membrane disruptors improves antimicrobial potency and broadens spectrum to gram-negative bacteria. Angew Chem Int Ed Engl 54(46):13617–13621. https://doi.org/10.1002/anie.201506814
Bera S, Mondal D, Palit S, Schweizer F (2016) Structural modifications of the neomycin class of aminoglycosides. MedChemComm 7(8):1499–1534. https://doi.org/10.1039/C6MD00079G
Bhattacharya D, Saha B, Mukherjee A, Ranjan Santra C, Karmakar P (2012) Gold nanoparticles conjugated antibiotics: stability and functional evaluation. Nanosci Nanotechnol 2(2):14–21. https://doi.org/10.5923/j.nn.20120202.04
Bhattacharya G, Dey D, Das S, Banerjee A (2017) Exposure to sub-inhibitory concentrations of gentamicin, ciprofloxacin and cefotaxime induces multidrug resistance and reactive oxygen species generation in meticillin-sensitive Staphylococcus aureus. J Med Microbiol 66(6):762–769. https://doi.org/10.1099/jmm.0.000492
Boehm A, Steiner S, Zaehringer F, Casanova A, Hamburger F, Ritz D, Keck W, Ackermann M, Schirmer T, Jenal U (2009) Second messenger signalling governs Escherichia coli biofilm induction upon ribosomal stress. Mol Microbiol 72(6):1500–1516. https://doi.org/10.1111/j.1365-2958.2009.06739.x
Bridier A, Sanchez-Vizuete P, Guilbaud M, Piard JC, Naitali M, Briandet R (2015) Biofilm-associated persistence of food-borne pathogens. Food Microbiol 45(Pt B):167–178. https://doi.org/10.1016/j.fm.2014.04.015
Cai Y, Fan Y, Wang R, An MM, Liang BB (2009) Synergistic effects of aminoglycosides and fosfomycin on Pseudomonas aeruginosain vitro and biofilm infections in a rat model. J Antimicrob Chemother 64(3):563–566. https://doi.org/10.1093/jac/dkp224
Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A (1999) The Calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 37(6):1771–1776
Cernohorska L, Votava M (2008) Antibiotic synergy against biofilm-forming Pseudomonas aeruginosa. Folia Microbiol (Praha) 53(1):57–60. https://doi.org/10.1007/s12223-008-0008-z
Chanda W, Joseph TP, Padhiar AA, Guo X, Min L, Wang W, Lolokote S, Ning A, Cao J, Huang M, Zhong M (2017) Combined effect of linolenic acid and tobramycin on Pseudomonas aeruginosa biofilm formation and quorum sensing. Exp Ther Med 14(5):4328–4338. https://doi.org/10.3892/etm.2017.5110
Chauhan A, Lebeaux D, Ghigo JM, Beloin C (2012) Full and broad-spectrum in vivo eradication of catheter-associated biofilms using gentamicin-EDTA antibiotic lock therapy. Antimicrob Agents Chemother 56(12):6310–6318. https://doi.org/10.1128/AAC.01606-12
Chen L, Wen YM (2011) The role of bacterial biofilm in persistent infections and control strategies. Int J Oral Sci 3(2):66–73. https://doi.org/10.4248/IJOS11022
Chiang WC, Nilsson M, Jensen PO, Hoiby N, Nielsen TE, Givskov M, Tolker-Nielsen T (2013) Extracellular DNA shields against aminoglycosides in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 57(5):2352–2361. https://doi.org/10.1128/AAC.00001-13
Chittapragada M, Roberts S, Ham YW (2009) Aminoglycosides: molecular insights on the recognition of RNA and aminoglycoside mimics. Perspect Medicin Chem 3:21–37. https://doi.org/10.4137/PMC.S2381
Chmielewski RAN, Frank JF (2003) Biofilm formation and control in food processing facilities. Compr Rev Food Sci Food Saf 2(1):22–32. https://doi.org/10.1111/j.1541-4337.2003.tb00012.x
Cole SJ, Records AR, Orr MW, Linden SB, Lee VT (2014) Catheter-associated urinary tract infection by Pseudomonas aeruginosa is mediated by exopolysaccharide-independent biofilms. Infect Immun 82(5):2048–2058. https://doi.org/10.1128/IAI.01652-14
Cox G, Ejim L, Stogios PJ, Koteva K, Bordeleau E, Evdokimova E, Sieron AO, Savchenko A, Serio AW, Krause KM, Wright GD (2018) Plazomicin retains antibiotic activity against most aminoglycoside modifying enzymes. ACS Infect Dis 4(6):980–987. https://doi.org/10.1021/acsinfecdis.8b00001
Crabbe A, Liu Y, Matthijs N, Rigole P, De La Fuente-Nunez C, Davis R, Ledesma MA, Sarker S, Van Houdt R, Hancock RE, Coenye T, Nickerson CA (2017) Antimicrobial efficacy against Pseudomonas aeruginosa biofilm formation in a three-dimensional lung epithelial model and the influence of fetal bovine serum. Sci Rep 7:43321–43313. https://doi.org/10.1038/srep43321
Das T, Sharma PK, Busscher HJ, van der Mei HC, Krom BP (2010) Role of extracellular DNA in initial bacterial adhesion and surface aggregation. Appl Environ Microbiol 76(10):3405–3408. https://doi.org/10.1128/AEM.03119-09
Davis BD (1987) Mechanism of bactericidal action of aminoglycosides. Microbiol Rev 51(3):341–350
Deacon J, Abdelghany SM, Quinn DJ, Schmid D, Megaw J, Donnelly RF, Jones DS, Kissenpfennig A, Elborn JS, Gilmore BF, Taggart CC, Scott CJ (2015) Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase). J Control Release 198:55–61. https://doi.org/10.1016/j.jconrel.2014.11.022
Di Domenico EG, Farulla I, Prignano G, Gallo MT, Vespaziani M, Cavallo I, Sperduti I, Pontone M, Bordignon V, Cilli L, De Santis A, Di Salvo F, Pimpinelli F, Lesnoni La Parola I, Toma L, Ensoli F (2017) Biofilm is a major virulence determinant in bacterial colonization of chronic skin ulcers independently from the multidrug resistant phenotype. Int J Mol Sci 18(5). https://doi.org/10.3390/ijms18051077
Dickey SW, Cheung GYC, Otto M (2017) Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance. Nat Rev Drug Discov 16(7):457–471. https://doi.org/10.1038/nrd.2017.23
Dong G, Liu H, Yu X, Zhang X, Lu H, Zhou T, Cao J (2018) Antimicrobial and anti-biofilm activity of tannic acid against Staphylococcus aureus. Nat Prod Res 32(18):2225–2228. https://doi.org/10.1080/14786419.2017.1366485
Dosler S, Karaaslan E (2014) Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides. Peptides 62:32–37. https://doi.org/10.1016/j.peptides.2014.09.021
Douafer H, Andrieu V, Phanstiel O, Brunel JM (2019) Antibiotic adjuvants: make antibiotics great again! J Med Chem. https://doi.org/10.1021/acs.jmedchem.8b01781
Drulis-Kawa Z, Dorotkiewicz-Jach A (2010) Liposomes as delivery systems for antibiotics. Int J Pharm 387(1–2):187–198. https://doi.org/10.1016/j.ijpharm.2009.11.033
Du J, Bandara HM, Du P, Huang H, Hoang K, Nguyen D, Mogarala SV, Smyth HD (2015) Improved biofilm antimicrobial activity of polyethylene glycol conjugated tobramycin compared to tobramycin in Pseudomonas aeruginosa biofilms. Mol Pharm 12(5):1544–1553. https://doi.org/10.1021/mp500846u
Eckert R, Brady KM, Greenberg EP, Qi F, Yarbrough DK, He J, McHardy I, Anderson MH, Shi W (2006) Enhancement of antimicrobial activity against Pseudomonas aeruginosa by coadministration of G10KHc and tobramycin. Antimicrob Agents Chemother 50(11):3833–3838. https://doi.org/10.1128/AAC.00509-06
El Zowalaty ME, Hussein Al Ali SH, Husseiny MI, Geilich BM, Webster TJ, Hussein MZ (2015) The ability of streptomycin-loaded chitosan-coated magnetic nanocomposites to possess antimicrobial and antituberculosis activities. Int J Nanomedicine 10:3269–3274. https://doi.org/10.2147/IJN.S74469
El-Say KM, El-Sawy HS (2017) Polymeric nanoparticles: promising platform for drug delivery. Int J Pharm 528(1–2):675–691. https://doi.org/10.1016/j.ijpharm.2017.06.052
Eom SH, Kang SK, Lee DS, Myeong JI, Lee J, Kim HW, Kim KH, Je JY, Jung WK, Kim YM (2016) Synergistic antibacterial effect and antibacterial action mode of chitosan-ferulic acid conjugate against methicillin-resistant Staphylococcus aureus. J Microbiol Biotechnol 26(4):784–789. https://doi.org/10.4014/jmb.1511.11046
Esteban J, Garcia-Coca M (2017) Mycobacterium biofilms. Front Microbiol 8:2651. https://doi.org/10.3389/fmicb.2017.02651
Fleitas Martinez O, Rigueiras PO, Pires ADS, Porto WF, Silva ON, de la Fuente-Nunez C, Franco OL (2018) Interference with quorum-sensing signal biosynthesis as a promising therapeutic strategy against multidrug-resistant pathogens. Front Cell Infect Microbiol 8:444. https://doi.org/10.3389/fcimb.2018.00444
Fleitas Martinez O, Cardoso MH, Ribeiro SM, Franco OL (2019) Recent advances in anti-virulence therapeutic strategies with a focus on dismantling bacterial membrane microdomains, toxin neutralization, quorum-sensing interference and biofilm inhibition. Front Cell Infect Microbiol 9:74. https://doi.org/10.3389/fcimb.2019.00074
Fong J, Zhang C, Yang R, Boo ZZ, Tan SK, Nielsen TE, Givskov M, Liu XW, Bin W, Su H, Yang L (2018) Combination therapy strategy of quorum quenching enzyme and quorum sensing inhibitor in suppressing multiple quorum sensing pathways of P. aeruginosa. Sci Rep 8(1):1155. https://doi.org/10.1038/s41598-018-19504-w
Fraud S, Poole K (2011) Oxidative stress induction of the MexXY multidrug efflux genes and promotion of aminoglycoside resistance development in Pseudomonas aeruginosa. Antimicrob Agents Chemother 55(3):1068–1074. https://doi.org/10.1128/AAC.01495-10
Furiga A, Lajoie B, El Hage S, Baziard G, Roques C (2015) Impairment of Pseudomonas aeruginosa biofilm resistance to antibiotics by combining the drugs with a new quorum-sensing inhibitor. Antimicrob Agents Chemother 60(3):1676–1686. https://doi.org/10.1128/AAC.02533-15
Gad El-Rab SMF, Halawani EM, Hassan A (2018) Formulation of ceftriaxone conjugated gold nanoparticles and their medical applications against extended-spectrum beta-lactamase producing bacteria and breast cancer. J Microbiol Biotechnol 28(9):1563–1572. https://doi.org/10.4014/jmb.1711.11037
Gagniere H, Di Martino P (2004) Effects of antibiotics on Pseudomonas aeruginosa NK125502 and Pseudomonas fluorescens MF0 biofilm formation on immobilized fibronectin. J Chemother 16(3):244–247. https://doi.org/10.1179/joc.2004.16.3.244
Galimand M, Lambert T, Courvalin P (2005) Emergence and dissemination of a new mechanism of resistance to aminoglycosides in Gram-negative bacteria: 16S rRNA methylation. Euro Surveill 10(1):E050127 2. https://doi.org/10.2807/esw.10.04.02626-en
Garneau-Tsodikova S, Labby KJ (2016) Mechanisms of resistance to aminoglycoside antibiotics: overview and perspectives. MedChemComm 7(1):11–27. https://doi.org/10.1039/C5MD00344J
Ghorbani H, Memar MY, Sefidan FY, Yekani M, Ghotaslou R (2017) In vitro synergy of antibiotic combinations against planktonic and biofilm Pseudomonas aeruginosa. GMS Hyg Infect Control 12:Doc17. https://doi.org/10.3205/dgkh000302
Giaouris E, Heir E, Desvaux M, Hebraud M, Moretro T, Langsrud S, Doulgeraki A, Nychas GJ, Kacaniova M, Czaczyk K, Olmez H, Simoes M (2015) Intra- and inter-species interactions within biofilms of important foodborne bacterial pathogens. Front Microbiol 6:841. https://doi.org/10.3389/fmicb.2015.00841
Giovagnoli S, Pietrella D, Barberini L, Santi C, Carotti A, di Michele A, Ricci M (2017) Reshaping antibiotics through hydrophobic drug-bile acid ionic complexation enhances activity against Staphylococcus aureus biofilms. Int J Pharm 528(1–2):144–162. https://doi.org/10.1016/j.ijpharm.2017.06.008
Gonzalez LS 3rd, Spencer JP (1998) Aminoglycosides: a practical review. Am Fam Physician 58(8):1811–1820
Gopu V, Meena CK, Shetty PH (2015) Quercetin influences quorum sensing in food borne bacteria: in-vitro and in-silico evidence. PLoS One 10(8):e0134684. https://doi.org/10.1371/journal.pone.0134684
Gupta P, Sarkar A, Sandhu P, Daware A, Das MC, Akhter Y, Bhattacharjee S (2017) Potentiation of antibiotic against Pseudomonas aeruginosa biofilm: a study with plumbagin and gentamicin. J Appl Microbiol 123(1):246–261. https://doi.org/10.1111/jam.13476
Habash MB, Goodyear MC, Park AJ, Surette MD, Vis EC, Harris RJ, Khursigara CM (2017) Potentiation of tobramycin by silver nanoparticles against Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 61(11). https://doi.org/10.1128/AAC.00415-17
Hari N, Nair AJ (2016) Development and characterization of chitosan-based antimicrobial films incorporated with streptomycin loaded starch nanoparticles. New Horiz Transl Med 3(1):22–29. https://doi.org/10.1016/j.nhtm.2016.04.002
Henry-Stanley MJ, Hess DJ, Wells CL (2014) Aminoglycoside inhibition of Staphylococcus aureus biofilm formation is nutrient dependent. J Med Microbiol 63(Pt 6):861–869. https://doi.org/10.1099/jmm.0.068130-0
Herrmann G, Yang L, Wu H, Song Z, Wang H, Hoiby N, Ulrich M, Molin S, Riethmuller J, Doring G (2010) Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa. J Infect Dis 202(10):1585–1592. https://doi.org/10.1086/656788
Hill M, Cunningham RN, Hathout RM, Johnston C, Hardy JG, Migaud ME (2019) Formulation of antimicrobial tobramycin loaded PLGA nanoparticles via complexation with AOT. J Funct Biomater 10(2). https://doi.org/10.3390/jfb10020026
Hirt H, Gorr SU (2013) Antimicrobial peptide GL13K is effective in reducing biofilms of Pseudomonas aeruginosa. Antimicrob Agents Chemother 57(10):4903–4910. https://doi.org/10.1128/AAC.00311-13
Hobbie SN, Pfister P, Bruell C, Sander P, Francois B, Westhof E, Bottger EC (2006) Binding of neomycin-class aminoglycoside antibiotics to mutant ribosomes with alterations in the A site of 16S rRNA. Antimicrob Agents Chemother 50(4):1489–1496. https://doi.org/10.1128/AAC.50.4.1489-1496.2006
Hoffman LR, D’Argenio DA, MacCoss MJ, Zhang Z, Jones RA, Miller SI (2005) Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 436(7054):1171–1175. https://doi.org/10.1038/nature03912
Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O (2010) Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 35(4):322–332. https://doi.org/10.1016/j.ijantimicag.2009.12.011
Hoiby N, Henneberg KA, Wang H, Stavnsbjerg C, Bjarnsholt T, Ciofu O, Johansen UR, Sams T (2019) Formation of Pseudomonas aeruginosa inhibition zone during tobramycin disk diffusion is due to transition from planktonic to biofilm mode of growth. Int J Antimicrob Agents 53(5):564–573. https://doi.org/10.1016/j.ijantimicag.2018.12.015
Hou Y, Wang Z, Zhang P, Bai H, Sun Y, Duan J, Mu H (2017) Lysozyme associated liposomal gentamicin inhibits bacterial biofilm. Int J Mol Sci 18(4). https://doi.org/10.3390/ijms18040784
Hou Y, Yang M, Jiang H, Li D, Du Y (2019) Effects of low-intensity and low-frequency ultrasound combined with tobramycin on biofilms of extended-spectrum beta-lactamases (ESBLs) Escherichia coli. FEMS Microbiol Lett 366(3). https://doi.org/10.1093/femsle/fnz026
Hu J, Quan Y, Lai Y, Zheng Z, Hu Z, Wang X, Dai T, Zhang Q, Cheng Y (2017) A smart aminoglycoside hydrogel with tunable gel degradation, on-demand drug release, and high antibacterial activity. J Control Release 247:145–152. https://doi.org/10.1016/j.jconrel.2017.01.003
Hussein-Al-Ali SH, El Zowalaty ME, Hussein MZ, Ismail M, Webster TJ (2014) Synthesis, characterization, controlled release, and antibacterial studies of a novel streptomycin chitosan magnetic nanoantibiotic. Int J Nanomedicine 9:549–557. https://doi.org/10.2147/IJN.S53079
Javaid A, Oloketuyi SF, Khan MM, Khan F (2018) Diversity of bacterial synthesis of silver nanoparticles. BioNanoScience 8(1):43–59. https://doi.org/10.1007/s12668-017-0496-x
Jeevanandam J, Barhoum A, Chan YS, Dufresne A, Danquah MK (2018) Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations. Beilstein J Nanotechnol 9:1050–1074. https://doi.org/10.3762/bjnano.9.98
Jia X, Zhang J, Sun W, He W, Jiang H, Chen D, Murchie AI (2013) Riboswitch control of aminoglycoside antibiotic resistance. Cell 152(1–2):68–81. https://doi.org/10.1016/j.cell.2012.12.019
Jijie R, Barras A, Teodorescu F, Boukherroub R, Szunerits S (2017) Advancements on the molecular design of nanoantibiotics: current level of development and future challenges. Mol Syst Des Eng 2(4):349–369. https://doi.org/10.1039/C7ME00048K
Jones C, Allsopp L, Horlick J, Kulasekara H, Filloux A (2013) Subinhibitory concentration of kanamycin induces the Pseudomonas aeruginosa type VI secretion system. PLoS One 8(11):e81132. https://doi.org/10.1371/journal.pone.0081132
Kaplan JB (2011) Antibiotic-induced biofilm formation. Int J Artif Organs 34(9):737–751. https://doi.org/10.5301/ijao.5000027
Kapoor P, Murphy P (2018) Combination antibiotics against Pseudomonas aeruginosa, representing common and rare cystic fibrosis strains from different Irish clinics. Heliyon 4(3):e00562. https://doi.org/10.1016/j.heliyon.2018.e00562
Khan I, Saeed K, Khan I (2017) Nanoparticles: properties, applications and toxicities. Arab J Chem. https://doi.org/10.1016/j.arabjc.2017.05.011
Khan F, Khan MM, Kim YM (2018) Recent progress and future perspectives of antibiofilm drugs immobilized on nanomaterials. Curr Pharm Biotechnol 19(8):631–643. https://doi.org/10.2174/1389201019666180828090052
Khan F, Javaid A, Kim YM (2019a) Functional diversity of quorum sensing receptors in pathogenic bacteria: interspecies, intraspecies and interkingdom level. Curr Drug Targets 20(6):655–667. https://doi.org/10.2174/1389450120666181123123333
Khan F, Lee JW, Pham DTN, Lee JH, Kim HW, Kim YK, Kim YM (2019b) Streptomycin mediated biofilm inhibition and suppression of virulence properties in Pseudomonas aeruginosa PAO1. Appl Microbiol Biotechnol 104:799–816. https://doi.org/10.1007/s00253-019-10190-w
Kim JH, Yu D, Eom SH, Kim SH, Oh J, Jung WK, Kim YM (2017) Synergistic antibacterial effects of chitosan-caffeic acid conjugate against antibiotic-resistant acne-related bacteria. Mar Drugs 15(6). https://doi.org/10.3390/md15060167
Kirby C, Gregoriadis G (1984) Dehydration-rehydration vesicles: a simple method for high yield drug entrapment in liposomes. Bio/Technology 2(11):979–984. https://doi.org/10.1038/nbt1184-979
Kondaveeti S, Bueno PVA, Carmona-Ribeiro AM, Esposito F, Lincopan N, Sierakowski MR, Petri DFS (2018) Microbicidal gentamicin-alginate hydrogels. Carbohydr Polym 186:159–167. https://doi.org/10.1016/j.carbpol.2018.01.044
Kora AJ, Rastogi L (2013) Enhancement of antibacterial activity of capped silver nanoparticles in combination with antibiotics, on model gram-negative and gram-positive bacteria. Bioinorg Chem Appl 2013:871097. https://doi.org/10.1155/2013/871097
Kotra LP, Haddad J, Mobashery S (2000) Aminoglycosides: perspectives on mechanisms of action and resistance and strategies to counter resistance. Antimicrob Agents Chemother 44(12):3249–3256. https://doi.org/10.1128/aac.44.12.3249-3256.2000
Krause KM, Serio AW, Kane TR, Connolly LE (2016) Aminoglycosides: an overview. Cold Spring Harb Perspect Med 6(6). https://doi.org/10.1101/cshperspect.a027029
Kumar A, Ting YP (2016) Streptomycin favors biofilm formation by altering cell surface properties. Appl Microbiol Biotechnol 100(20):8843–8853. https://doi.org/10.1007/s00253-016-7793-0
Labby KJ, Garneau-Tsodikova S (2013) Strategies to overcome the action of aminoglycoside-modifying enzymes for treating resistant bacterial infections. Future Med Chem 5(11):1285–1309. https://doi.org/10.4155/fmc.13.80
Landman D, Kelly P, Backer M, Babu E, Shah N, Bratu S, Quale J (2011) Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City. J Antimicrob Chemother 66(2):332–334. https://doi.org/10.1093/jac/dkq459
Langner M, Kral TE (1999) Liposome-based drug delivery systems. Pol J Pharmacol 51(3):211–222
Lebeaux D, Chauhan A, Letoffe S, Fischer F, de Reuse H, Beloin C, Ghigo JM (2014) pH-mediated potentiation of aminoglycosides kills bacterial persisters and eradicates in vivo biofilms. J Infect Dis 210(9):1357–1366. https://doi.org/10.1093/infdis/jiu286
Lebeaux D, Leflon-Guibout V, Ghigo JM, Beloin C (2015) In vitro activity of gentamicin, vancomycin or amikacin combined with EDTA or l-arginine as lock therapy against a wide spectrum of biofilm-forming clinical strains isolated from catheter-related infections. J Antimicrob Chemother 70(6):1704–1712. https://doi.org/10.1093/jac/dkv044
Li B, Webster TJ (2018) Bacteria antibiotic resistance: new challenges and opportunities for implant-associated orthopedic infections. J Orthop Res 36(1):22–32. https://doi.org/10.1002/jor.23656
Li X, Wu B, Chen H, Nan K, Jin Y, Sun L, Wang B (2018) Recent developments in smart antibacterial surfaces to inhibit biofilm formation and bacterial infections. J Mater Chem B 6(26):4274–4292. https://doi.org/10.1039/C8TB01245H
Li R, Yuan X, Wei J, Zhang X, Cheng G, Wang ZA, Du Y (2019) Synthesis and evaluation of a chitosan oligosaccharide-streptomycin conjugate against Pseudomonas aeruginosa biofilms. Mar Drugs 17(1). https://doi.org/10.3390/md17010043
Lin J, Nishino K, Roberts MC, Tolmasky M, Aminov RI, Zhang L (2015) Mechanisms of antibiotic resistance. Front Microbiol 6:34. https://doi.org/10.3389/fmicb.2015.00034
Linares JF, Gustafsson I, Baquero F, Martinez JL (2006) Antibiotics as intermicrobial signaling agents instead of weapons. Proc Natl Acad Sci U S A 103(51):19484–19489. https://doi.org/10.1073/pnas.0608949103
Liu Z, Jiao Y, Wang Y, Zhou C, Zhang Z (2008) Polysaccharides-based nanoparticles as drug delivery systems. Adv Drug Deliv Rev 60(15):1650–1662. https://doi.org/10.1016/j.addr.2008.09.001
Liu Z, Wang W, Zhu Y, Gong Q, Yu W, Lu X (2013) Antibiotics at subinhibitory concentrations improve the quorum sensing behavior of Chromobacterium violaceum. FEMS Microbiol Lett 341(1):37–44. https://doi.org/10.1111/1574-6968.12086
Liu Q, Niu H, Zhang W, Mu H, Sun C, Duan J (2015) Synergy among thymol, eugenol, berberine, cinnamaldehyde and streptomycin against planktonic and biofilm-associated food-borne pathogens. Lett Appl Microbiol 60(5):421–430. https://doi.org/10.1111/lam.12401
Liu Y, Ji P, Lv H, Qin Y, Deng L (2017) Gentamicin modified chitosan film with improved antibacterial property and cell biocompatibility. Int J Biol Macromol 98:550–556. https://doi.org/10.1016/j.ijbiomac.2017.01.121
Magnet S, Smith TA, Zheng R, Nordmann P, Blanchard JS (2003) Aminoglycoside resistance resulting from tight drug binding to an altered aminoglycoside acetyltransferase. Antimicrob Agents Chemother 47(5):1577–1583. https://doi.org/10.1128/aac.47.5.1577-1583.2003
Maiden MM, Hunt AMA, Zachos MP, Gibson JA, Hurwitz ME, Mulks MH, Waters CM (2018) Triclosan is an aminoglycoside adjuvant for eradication of Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 62(6). https://doi.org/10.1128/AAC.00146-18
Maura D, Drees SL, Bandyopadhaya A, Kitao T, Negri M, Starkey M, Lesic B, Milot S, Deziel E, Zahler R, Pucci M, Felici A, Fetzner S, Lepine F, Rahme LG (2017) Polypharmacology approaches against the Pseudomonas aeruginosa MvfR regulon and their application in blocking virulence and antibiotic tolerance. ACS Chem Biol 12(5):1435–1443. https://doi.org/10.1021/acschembio.6b01139
Mingeot-Leclercq MP, Glupczynski Y, Tulkens PM (1999) Aminoglycosides: activity and resistance. Antimicrob Agents Chemother 43(4):727–737
Moreau-Marquis S, Coutermarsh B, Stanton BA (2015) Combination of hypothiocyanite and lactoferrin (ALX-109) enhances the ability of tobramycin and aztreonam to eliminate Pseudomonas aeruginosa biofilms growing on cystic fibrosis airway epithelial cells. J Antimicrob Chemother 70(1):160–166. https://doi.org/10.1093/jac/dku357
Morikawa K, Nonaka M, Yoshikawa Y, Torii I (2005) Synergistic effect of fosfomycin and arbekacin on a methicillin-resistant Staphylococcus aureus-induced biofilm in a rat model. Int J Antimicrob Agents 25(1):44–50. https://doi.org/10.1016/j.ijantimicag.2004.07.015
Morita Y, Tomida J, Kawamura Y (2012a) MexXY multidrug efflux system of Pseudomonas aeruginosa. Front Microbiol 3:408. https://doi.org/10.3389/fmicb.2012.00408
Morita Y, Tomida J, Kawamura Y (2012b) Primary mechanisms mediating aminoglycoside resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7. Microbiology 158(Pt 4):1071–1083. https://doi.org/10.1099/mic.0.054320-0
Mosselhy DA, He W, Hynonen U, Meng Y, Mohammadi P, Palva A, Feng Q, Hannula SP, Nordstrom K, Linder MB (2018) Silica-gentamicin nanohybrids: combating antibiotic resistance, bacterial biofilms, and in vivo toxicity. Int J Nanomedicine 13:7939–7957. https://doi.org/10.2147/IJN.S182611
Mourtas S, Diamanti G, Foka A, Dracopoulos V, Klepetsanis P, Stamouli V, Spiliopoulou I, Antimisiaris SG (2015) Inhibition of bacterial attachment on surfaces by immobilization of tobramycin-loaded liposomes. J Biomed Nanotechnol 11(12):2186–2196
Mu H, Guo F, Niu H, Liu Q, Wang S, Duan J (2014) Chitosan improves anti-biofilm efficacy of gentamicin through facilitating antibiotic penetration. Int J Mol Sci 15(12):22296–22308. https://doi.org/10.3390/ijms151222296
Mu H, Liu Q, Niu H, Sun Y, Duan J (2016a) Gold nanoparticles make chitosan–streptomycin conjugates effective towards Gram-negative bacterial biofilm. RSC Adv 6(11):8714–8721. https://doi.org/10.1039/C5RA22803D
Mu H, Niu H, Wang D, Sun F, Sun Y, Duan J (2016b) Chitosan conjugation enables intracellular bacteria susceptible to aminoglycoside antibiotic. Glycobiology 26(11):1190–1197. https://doi.org/10.1093/glycob/cww079
Mu H, Tang J, Liu Q, Sun C, Wang T, Duan J (2016c) Potent antibacterial nanoparticles against biofilm and intracellular bacteria. Sci Rep 6:18877. https://doi.org/10.1038/srep18877
Mugabe C, Azghani AO, Omri A (2006a) Preparation and characterization of dehydration-rehydration vesicles loaded with aminoglycoside and macrolide antibiotics. Int J Pharm 307(2):244–250. https://doi.org/10.1016/j.ijpharm.2005.10.005
Mugabe C, Halwani M, Azghani AO, Lafrenie RM, Omri A (2006b) Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother 50(6):2016–2022. https://doi.org/10.1128/AAC.01547-05
Mulani MS, Kamble EE, Kumkar SN, Tawre MS, Pardesi KR (2019) Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: a review. Front Microbiol 10:539. https://doi.org/10.3389/fmicb.2019.00539
Mulcahy H, Charron-Mazenod L, Lewenza S (2008) Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms. PLoS Pathog 4(11):e1000213. https://doi.org/10.1371/journal.ppat.1000213
Nair S, Desai S, Poonacha N, Vipra A, Sharma U (2016) Antibiofilm activity and synergistic inhibition of Staphylococcus aureus biofilms by bactericidal protein P128 in combination with antibiotics. Antimicrob Agents Chemother 60(12):7280–7289. https://doi.org/10.1128/AAC.01118-16
Nguyen TK, Selvanayagam R, Ho KKK, Chen R, Kutty SK, Rice SA, Kumar N, Barraud N, Duong HTT, Boyer C (2016) Co-delivery of nitric oxide and antibiotic using polymeric nanoparticles. Chem Sci 7(2):1016–1027. https://doi.org/10.1039/c5sc02769a
Noone P (1984) Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use. Drugs 27(6):548–578. https://doi.org/10.2165/00003495-198427060-00003
O’Connell HA, Kottkamp GS, Eppelbaum JL, Stubblefield BA, Gilbert SE, Gilbert ES (2006) Influences of biofilm structure and antibiotic resistance mechanisms on indirect pathogenicity in a model polymicrobial biofilm. Appl Environ Microbiol 72(7):5013–5019. https://doi.org/10.1128/AEM.02474-05
Olivares J, Bernardini A, Garcia-Leon G, Corona F, Sanchez M, Martinez JL (2013) The intrinsic resistome of bacterial pathogens. Front Microbiol 4:103. https://doi.org/10.3389/fmicb.2013.00103
Pang Z, Raudonis R, Glick BR, Lin TJ, Cheng Z (2019) Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. Biotechnol Adv 37(1):177–192. https://doi.org/10.1016/j.biotechadv.2018.11.013
Payne JN, Waghwani HK, Connor MG, Hamilton W, Tockstein S, Moolani H, Chavda F, Badwaik V, Lawrenz MB, Dakshinamurthy R (2016) Novel synthesis of kanamycin conjugated gold nanoparticles with potent antibacterial activity. Front Microbiol 7:607. https://doi.org/10.3389/fmicb.2016.00607
Perez-Rodriguez F, Mercanoglu Taban B (2019) A state-of-art review on multi-drug resistant pathogens in foods of animal origin: risk factors and mitigation strategies. Front Microbiol 10:2091. https://doi.org/10.3389/fmicb.2019.02091
Perni S, Prokopovich P (2014) Continuous release of gentamicin from gold nanocarriers. RSC Adv 4(94):51904–51910. https://doi.org/10.1039/c4ra10023a
Peterson E, Kaur P (2018) Antibiotic resistance mechanisms in bacteria: relationships between resistance determinants of antibiotic producers, environmental bacteria, and clinical pathogens. Front Microbiol 9:2928. https://doi.org/10.3389/fmicb.2018.02928
Radlinski LC, Rowe SE, Brzozowski R, Wilkinson AD, Huang R, Eswara P, Conlon BP (2019) Chemical induction of aminoglycoside uptake overcomes antibiotic tolerance and resistance in Staphylococcus aureus. Cell Chem Biol 26(10):1355–1364 e4. https://doi.org/10.1016/j.chembiol.2019.07.009
Ramirez MS, Tolmasky ME (2010) Aminoglycoside modifying enzymes. Drug Resist Updat 13(6):151–171. https://doi.org/10.1016/j.drup.2010.08.003
Ramirez MS, Nikolaidis N, Tolmasky ME (2013) Rise and dissemination of aminoglycoside resistance: the aac(6′)-Ib paradigm. Front Microbiol 4:121. https://doi.org/10.3389/fmicb.2013.00121
Ranieri MR, Whitchurch CB, Burrows LL (2018) Mechanisms of biofilm stimulation by subinhibitory concentrations of antimicrobials. Curr Opin Microbiol 45:164–169. https://doi.org/10.1016/j.mib.2018.07.006
Rasko DA, Sperandio V (2010) Anti-virulence strategies to combat bacteria-mediated disease. Nat Rev Drug Discov 9(2):117–128. https://doi.org/10.1038/nrd3013
Reyes N, Aggen JB, Kostrub CF (2011) In vivo efficacy of the novel aminoglycoside ACHN-490 in murine infection models. Antimicrob Agents Chemother 55(4):1728–1733. https://doi.org/10.1128/AAC.00862-10
Rojo-Molinero E, Macia MD, Rubio R, Moya B, Cabot G, Lopez-Causape C, Perez JL, Canton R, Oliver A (2016) Sequential treatment of biofilms with aztreonam and tobramycin is a novel strategy for combating Pseudomonas aeruginosa chronic respiratory infections. Antimicrob Agents Chemother 60(5):2912–2922. https://doi.org/10.1128/AAC.00196-16
Roshmi T, Soumya KR, Jyothis M, Radhakrishnan EK (2015) Effect of biofabricated gold nanoparticle-based antibiotic conjugates on minimum inhibitory concentration of bacterial isolates of clinical origin. Gold Bull 48(1):63–71. https://doi.org/10.1007/s13404-015-0162-4
Rukholm G, Mugabe C, Azghani AO, Omri A (2006) Antibacterial activity of liposomal gentamicin against Pseudomonas aeruginosa: a time-kill study. Int J Antimicrob Agents 27(3):247–252. https://doi.org/10.1016/j.ijantimicag.2005.10.021
Sabaeifard P, Abdi-Ali A, Gamazo C, Irache JM, Soudi MR (2017) Improved effect of amikacin-loaded poly(D,L-lactide-co-glycolide) nanoparticles against planktonic and biofilm cells of Pseudomonas aeruginosa. J Med Microbiol 66(2):137–148. https://doi.org/10.1099/jmm.0.000430
Salouti M, Ahangari A (2014) Nanoparticle based drug delivery systems for treatment of infectious diseases. In: Ali DS (ed) Application of nanotechnology in drug delivery, IntechOpen. https://doi.org/10.5772/58423.
Saroj SD, Rather PN (2013) Streptomycin inhibits quorum sensing in Acinetobacter baumannii. Antimicrob Agents Chemother 57(4):1926–1929. https://doi.org/10.1128/AAC.02161-12
Sato Y, Unno Y, Ubagai T, Ono Y (2018) Sub-minimum inhibitory concentrations of colistin and polymyxin B promote Acinetobacter baumannii biofilm formation. PLoS One 13(3):e0194556. https://doi.org/10.1371/journal.pone.0194556
Sautrey G, Zimmermann L, Deleu M, Delbar A, Souza Machado L, Jeannot K, Van Bambeke F, Buyck JM, Decout JL, Mingeot-Leclercq MP (2014) New amphiphilic neamine derivatives active against resistant Pseudomonas aeruginosa and their interactions with lipopolysaccharides. Antimicrob Agents Chemother 58(8):4420–4430. https://doi.org/10.1128/AAC.02536-13
Schroeder M, Brooks BD, Brooks AE (2017) The complex relationship between virulence and antibiotic resistance. Genes (Basel) 8(1). https://doi.org/10.3390/genes8010039
Shah M, Badwaik V, Kherde Y, Waghwani HK, Modi T, Aguilar ZP, Rodgers H, Hamilton W, Marutharaj T, Webb C, Lawrenz MB, Dakshinamurthy R (2014) Gold nanoparticles: various methods of synthesis and antibacterial applications. Front Biosci (Landmark Ed) 19:1320–1344
Shakil S, Khan R, Zarrilli R, Khan AU (2008) Aminoglycosides versus bacteria—a description of the action, resistance mechanism, and nosocomial battleground. J Biomed Sci 15(1):5–14. https://doi.org/10.1007/s11373-007-9194-y
Shedbalkar U, Singh R, Wadhwani S, Gaidhani S, Chopade BA (2014) Microbial synthesis of gold nanoparticles: current status and future prospects. Adv Colloid Interf Sci 209:40–48. https://doi.org/10.1016/j.cis.2013.12.011
Shin B, Park W (2015) Synergistic effect of oleanolic acid on aminoglycoside antibiotics against Acinetobacter baumannii. PLoS One 10(9):e0137751. https://doi.org/10.1371/journal.pone.0137751
Springer B, Kidan YG, Prammananan T, Ellrott K, Bottger EC, Sander P (2001) Mechanisms of streptomycin resistance: selection of mutations in the 16S rRNA gene conferring resistance. Antimicrob Agents Chemother 45(10):2877–2884. https://doi.org/10.1128/AAC.45.10.2877-2884.2001
Szczuka E, Jablonska L, Kaznowski A (2017) Effect of subinhibitory concentrations of tigecycline and ciprofloxacin on the expression of biofilm-associated genes and biofilm structure of Staphylococcus epidermidis. Microbiology 163(5):712–718. https://doi.org/10.1099/mic.0.000453
Taber HW, Mueller JP, Miller PF, Arrow AS (1987) Bacterial uptake of aminoglycoside antibiotics. Microbiol Rev 51(4):439–457
Tahrioui A, Duchesne R, Bouffartigues E, Rodrigues S, Maillot O, Tortuel D, Hardouin J, Taupin L, Groleau M-C, Dufour A, Déziel E, Brenner-Weiss G, Feuilloley M, Orange N, Lesouhaitier O, Cornelis P, Chevalier S (2019) Extracellular DNA release, quorum sensing, and PrrF1/F2 small RNAs are key players in Pseudomonas aeruginosa tobramycin-enhanced biofilm formation. NPJ Biofilms Microbiomes 5(1):15. https://doi.org/10.1038/s41522-019-0088-3
Thamban Chandrika N, Garneau-Tsodikova S (2018) Comprehensive review of chemical strategies for the preparation of new aminoglycosides and their biological activities. Chem Soc Rev 47(4):1189–1249. https://doi.org/10.1039/c7cs00407a
Traugott KA, Echevarria K, Maxwell P, Green K, Lewis JS 2nd (2011) Monotherapy or combination therapy? The Pseudomonas aeruginosa conundrum. Pharmacotherapy 31(6):598–608. https://doi.org/10.1592/phco.31.6.598
Tseng JT, Bryan LE, Van den Elzen HM (1972) Mechanisms and spectrum of streptomycin resistance in a natural population of Pseudomonas aeruginosa. Antimicrob Agents Chemother 2(3):136–141. https://doi.org/10.1128/aac.2.3.136
Tukenmez H, Edstrom I, Ummanni R, Fick SB, Sundin C, Elofsson M, Larsson C (2019) Mycobacterium tuberculosis virulence inhibitors discovered by Mycobacterium marinum high-throughput screening. Sci Rep 9(1):26. https://doi.org/10.1038/s41598-018-37176-4
Tyers M, Wright GD (2019) Drug combinations: a strategy to extend the life of antibiotics in the 21st century. Nat Rev Microbiol 17(3):141–155. https://doi.org/10.1038/s41579-018-0141-x
Van Giau V, An SSA, Hulme J (2019) Recent advances in the treatment of pathogenic infections using antibiotics and nano-drug delivery vehicles. Drug Des Devel Ther 13:327–343. https://doi.org/10.2147/DDDT.S190577
Vestergaard M, Nohr-Meldgaard K, Ingmer H (2018) Multiple pathways towards reduced membrane potential and concomitant reduction in aminoglycoside susceptibility in Staphylococcus aureus. Int J Antimicrob Agents 51(1):132–135. https://doi.org/10.1016/j.ijantimicag.2017.08.024
Vipin C, Mujeeburahiman M, Saptami K, Arun AB, Rekha PD (2019) Synergistic interactions of quercetin with antibiotics against biofilm associated clinical isolates of Pseudomonas aeruginosa in vitro:601336. https://doi.org/10.1101/601336%JbioRxiv
Walter F, Vicens Q, Westhof E (1999) Aminoglycoside-RNA interactions. Curr Opin Chem Biol 3(6):694–704
Wang X, Deng A, Cao W, Li Q, Wang L, Zhou J, Hu B, Xing X (2018a) Synthesis of chitosan/poly (ethylene glycol)-modified magnetic nanoparticles for antibiotic delivery and their enhanced anti-biofilm activity in the presence of magnetic field. J Mater Sci 53(9):6433–6449. https://doi.org/10.1007/s10853-018-1998-9
Wang Z, Qiu Y, Hou C, Wang D, Sun F, Li X, Wang F, Yi H, Mu H, Duan J (2018b) Synthesis of hyaluronan-amikacin conjugate and its bactericidal activity against intracellular bacteria in vitro and in vivo. Carbohydr Polym 181:132–140. https://doi.org/10.1016/j.carbpol.2017.10.061
Westbrock-Wadman S, Sherman DR, Hickey MJ, Coulter SN, Zhu YQ, Warrener P, Nguyen LY, Shawar RM, Folger KR, Stover CK (1999) Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability. Antimicrob Agents Chemother 43(12):2975–2983
Wilton M, Charron-Mazenod L, Moore R, Lewenza S (2016) Extracellular DNA acidifies biofilms and induces aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 60(1):544–553. https://doi.org/10.1128/AAC.01650-15
Wistrand-Yuen E, Knopp M, Hjort K, Koskiniemi S, Berg OG, Andersson DI (2018) Evolution of high-level resistance during low-level antibiotic exposure. Nat Commun 9(1):1599. https://doi.org/10.1038/s41467-018-04059-1
Wojnicz D, Tichaczek-Goska D (2013) Effect of sub-minimum inhibitory concentrations of ciprofloxacin, amikacin and colistin on biofilm formation and virulence factors of Escherichia coli planktonic and biofilm forms isolated from human urine. Braz J Microbiol 44(1):259–265. https://doi.org/10.1590/S1517-83822013000100037
Wright GD (2016) Antibiotic adjuvants: rescuing antibiotics from resistance. Trends Microbiol 24(11):862–871. https://doi.org/10.1016/j.tim.2016.06.009
Yan T, Li C, Ouyang Q, Zhang D, Zhong Q, Li P, Li S, Yang Z, Wang T, Zhao Q (2019) Synthesis of gentamicin-grafted-chitosan with improved solubility and antibacterial activity. React Funct Polym 137:38–45. https://doi.org/10.1016/j.reactfunctpolym.2019.01.013
Yang B, Lei Z, Zhao Y, Ahmed S, Wang C, Zhang S, Fu S, Cao J, Qiu Y (2017) Combination susceptibility testing of common antimicrobials in vitro and the effects of sub-MIC of antimicrobials on Staphylococcus aureus biofilm formation. Front Microbiol 8:2125. https://doi.org/10.3389/fmicb.2017.02125
Yarlagadda V, Wright GD (2019) Membrane-active rhamnolipids overcome aminoglycoside resistance. Cell Chem Biol 26(10):1333–1334. https://doi.org/10.1016/j.chembiol.2019.09.015
Yoshikawa Y, Morikawa K, Nonaka M, Torii I (2004) Effect of arbekacin on a methicillin-resistant Staphylococcus aureus-induced biofilm in a rat model. J Infect Chemother 10(5):268–273. https://doi.org/10.1007/s10156-004-0336-0
Yu W, Hallinen KM, Wood KB (2018) Interplay between antibiotic efficacy and drug-induced lysis underlies enhanced biofilm formation at subinhibitory drug concentrations. Antimicrob Agents Chemother 62(1). https://doi.org/10.1128/AAC.01603-17
Zarate SG, De la Cruz Claure ML, Benito-Arenas R, Revuelta J, Santana AG, Bastida A (2018) Overcoming aminoglycoside enzymatic resistance: design of novel antibiotics and inhibitors. Molecules 23(2). https://doi.org/10.3390/molecules23020284
Zhang A, Mu H, Zhang W, Cui G, Zhu J, Duan J (2013) Chitosan coupling makes microbial biofilms susceptible to antibiotics. Sci Rep 3:3364. https://doi.org/10.1038/srep03364
Zhou JW, Hou B, Liu GY, Jiang H, Sun B, Wang ZN, Shi RF, Xu Y, Wang R, Jia AQ (2018a) Attenuation of Pseudomonas aeruginosa biofilm by hordenine: a combinatorial study with aminoglycoside antibiotics. Appl Microbiol Biotechnol 102(22):9745–9758. https://doi.org/10.1007/s00253-018-9315-8
Zhou JW, Luo HZ, Jiang H, Jian TK, Chen ZQ, Jia AQ (2018b) Hordenine: a novel quorum sensing inhibitor and antibiofilm agent against Pseudomonas aeruginosa. J Agric Food Chem 66(7):1620–1628. https://doi.org/10.1021/acs.jafc.7b05035
Acknowledgments
We would like to thank Raksha Anand, School of Basic Sciences and Research, Sharda University, India, for English language editing.
Funding
This work was supported by the Pukyong National University Research Fund in 2019.
Author information
Authors and Affiliations
Contributions
FK and YMK conceived the idea. FK, DTNP, and YMK were involved in the literature search and writing of the manuscript. FK and YMK edited the manuscript. All authors read and approved the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Khan, F., Pham, D.T.N. & Kim, YM. Alternative strategies for the application of aminoglycoside antibiotics against the biofilm-forming human pathogenic bacteria. Appl Microbiol Biotechnol 104, 1955–1976 (2020). https://doi.org/10.1007/s00253-020-10360-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00253-020-10360-1